MX2018000570A - Nuevas isoformas de tripsina y su uso. - Google Patents

Nuevas isoformas de tripsina y su uso.

Info

Publication number
MX2018000570A
MX2018000570A MX2018000570A MX2018000570A MX2018000570A MX 2018000570 A MX2018000570 A MX 2018000570A MX 2018000570 A MX2018000570 A MX 2018000570A MX 2018000570 A MX2018000570 A MX 2018000570A MX 2018000570 A MX2018000570 A MX 2018000570A
Authority
MX
Mexico
Prior art keywords
isoforms
novel trypsin
trypsin isoforms
novel
relates
Prior art date
Application number
MX2018000570A
Other languages
English (en)
Inventor
Gudmundsdottir Agusta
Asgeirsson Asgeir
Stefansson Bjarki
Original Assignee
Enzymatica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzymatica Ab filed Critical Enzymatica Ab
Publication of MX2018000570A publication Critical patent/MX2018000570A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6408—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21004—Trypsin (3.4.21.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Pulmonology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)

Abstract

La presente invención se refiere a nuevas isoformas de tripsina ZT. En particular, la invención se refiere al uso de isoformas de tripsina ZT en dispositivos médicos, productos farmacéuticos y cosméticos.
MX2018000570A 2015-07-24 2016-07-22 Nuevas isoformas de tripsina y su uso. MX2018000570A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15178208.3A EP3121272A1 (en) 2015-07-24 2015-07-24 Novel fish trypsin isoforms and their use
PCT/EP2016/067531 WO2017017012A1 (en) 2015-07-24 2016-07-22 Novel trypsin isoforms and their use

Publications (1)

Publication Number Publication Date
MX2018000570A true MX2018000570A (es) 2018-08-09

Family

ID=53758073

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018000570A MX2018000570A (es) 2015-07-24 2016-07-22 Nuevas isoformas de tripsina y su uso.

Country Status (19)

Country Link
US (2) US11179311B2 (es)
EP (3) EP3121272A1 (es)
JP (2) JP6869979B2 (es)
KR (1) KR20180032588A (es)
CN (2) CN113846079A (es)
AU (1) AU2016299760B2 (es)
BR (1) BR112018001404A2 (es)
CA (1) CA2992821A1 (es)
DK (3) DK3325618T3 (es)
ES (1) ES2813551T3 (es)
HR (1) HRP20201290T1 (es)
HU (1) HUE050121T2 (es)
MX (1) MX2018000570A (es)
PL (1) PL3325618T3 (es)
PT (1) PT3325618T (es)
RS (1) RS60711B1 (es)
RU (1) RU2739945C2 (es)
SI (1) SI3325618T1 (es)
WO (1) WO2017017012A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3121272A1 (en) 2015-07-24 2017-01-25 Zymetech ehf. Novel fish trypsin isoforms and their use
GB201701315D0 (en) 2017-01-26 2017-03-15 Enzymatica Ab Novel treatments
GB201800274D0 (en) * 2018-01-08 2018-02-21 Enzymatica Ab Novel treatments
GB201801982D0 (en) 2018-02-07 2018-03-28 Enzymatica Ab Novel treatments
WO2020229145A1 (en) * 2019-05-13 2020-11-19 Bioseutica B.V. Purified fish proteases with high specific activities and its process of production
US11441261B2 (en) 2020-09-10 2022-09-13 WABESO Enhanced Enzymatics, Inc. Self-sterilizing fabrics incorporating anti-viral cold-active proteases
WO2023012224A1 (en) * 2021-08-03 2023-02-09 Zymiq Technology Ab Peptidase formulation for treatment of microbial infections in the upper respiratory tract
WO2024044679A2 (en) * 2022-08-24 2024-02-29 Ohio State Innovation Foundation Methods of synthesizing peptides with free n-terminal cysteine and products thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8302268L (sv) 1983-04-22 1984-10-23 Lars G I Hellgren Ny kombination av proteolytiska och lipolytiska enzymer lemplig som tvettkomposition
EP0107634B1 (en) 1982-10-25 1989-04-12 Lars Gustav Inge Hellgren Enzyme composition for cleaning, the use thereof and preparation of the composition
SE454566B (sv) 1984-04-24 1988-05-16 Lars G I Hellgren Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus
JPS6130527A (ja) 1984-07-20 1986-02-12 Kao Corp 血栓溶解剤
US6030612A (en) 1994-11-22 2000-02-29 Phairson Medical Inc. Antimicrobial uses of multifunctional enzyme
MXPA01013246A (es) * 1999-06-18 2003-08-20 Jon Bragi Bjarnason Proteinasas serina de pescado y su uso farmaceutico y cosmetico.
EP1227736B1 (en) 1999-10-20 2004-01-07 Nordur EHF Protein hydrolysates produced with the use of marine proteases
RU2286171C1 (ru) * 2005-04-12 2006-10-27 Эдуард Артемович Макарян Препарат для профилактики и лечения респираторных и желудочно-кишечных инфекционных заболеваний бактериальной и вирусной этиологии сельскохозяйственных животных и способ профилактики и лечения респираторных и желудочно-кишечных инфекционных заболеваний бактериальной и вирусной этиологии сельскохозяйственных животных
WO2008045148A2 (en) * 2006-07-05 2008-04-17 Catalyst Biosciences, Inc. Protease screening methods and proteases identified thereby
CN101250574A (zh) * 2007-03-22 2008-08-27 中国海洋大学 一种梯级分子量鳕鱼鱼皮胶原肽的制备方法
CA2780756A1 (en) 2009-11-23 2011-05-26 Prothera, Inc. Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
GB0921288D0 (en) * 2009-12-04 2010-01-20 Health Prot Agency Therapies for preventing or suppressing clostridium difficile infection
SG195190A1 (en) 2011-05-31 2013-12-30 Hutchison Biofilm Medical Solutions Ltd Dispersion and detachment of cell aggregates
CN102228126B (zh) * 2011-06-10 2013-03-13 天津市虎豹调味品酿造有限公司何庄分公司 一种鳕鱼骨水解蛋白液的制备方法
CN103320485B (zh) * 2013-06-03 2015-12-23 王南平 一种医用级生物材料用鱼皮胶原的制备方法
EP3121272A1 (en) * 2015-07-24 2017-01-25 Zymetech ehf. Novel fish trypsin isoforms and their use

Also Published As

Publication number Publication date
RU2020142400A (ru) 2021-02-11
DK3325618T3 (da) 2020-08-10
EP3121272A1 (en) 2017-01-25
JP7116823B2 (ja) 2022-08-10
PT3325618T (pt) 2020-09-04
AU2016299760B2 (en) 2021-11-18
JP6869979B2 (ja) 2021-05-12
EP3736331A1 (en) 2020-11-11
CN107849551A (zh) 2018-03-27
DK202070808A1 (en) 2021-02-26
CN113846079A (zh) 2021-12-28
CA2992821A1 (en) 2017-02-02
AU2016299760A1 (en) 2018-02-01
ES2813551T3 (es) 2021-03-24
BR112018001404A2 (pt) 2018-09-11
JP2018520707A (ja) 2018-08-02
US20220062148A1 (en) 2022-03-03
RS60711B1 (sr) 2020-09-30
RU2018106533A (ru) 2019-08-26
JP2021106603A (ja) 2021-07-29
EP3325618A1 (en) 2018-05-30
PL3325618T3 (pl) 2020-11-16
WO2017017012A1 (en) 2017-02-02
CN107849551B (zh) 2021-11-02
RU2018106533A3 (es) 2020-01-30
DK180405B1 (en) 2021-04-14
RU2739945C2 (ru) 2020-12-30
US11179311B2 (en) 2021-11-23
US11918674B2 (en) 2024-03-05
KR20180032588A (ko) 2018-03-30
SI3325618T1 (sl) 2020-12-31
EP3325618B1 (en) 2020-05-27
US20200197288A1 (en) 2020-06-25
HRP20201290T1 (hr) 2020-11-13
DK181080B1 (en) 2022-11-29
DK201870049A1 (en) 2018-02-05
HUE050121T2 (hu) 2020-11-30

Similar Documents

Publication Publication Date Title
MX2018000570A (es) Nuevas isoformas de tripsina y su uso.
PH12017502297A1 (en) Antibacterial compounds
AU201612779S (en) Oral care implement
AU201612764S (en) Oral care implement
MY187540A (en) Compounds active towards bromodomains
MX2016017108A (es) Composiciones y metodos para el cuidado personal.
PH12019501970A1 (en) Pharmaceutical compositions for combination therapy
BR112017011215A2 (pt) partículas de distribuição de pró-flavorizante
IL271492A (en) Use of cannabidiol in the treatment of multiple sclerosis complex
AU201612816S (en) Oral care implement
MX2015009106A (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
PH12019501301A1 (en) Pharmaceutical compositions for combination therapy
AU201715033S (en) Dental vibration device
AU201612579S (en) Oral care implement
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
MX2017012595A (es) Un extracto de indigo naturalis y un proceso para preparar el mismo.
MX2017000862A (es) Formulacion de factor viii.
PH12016501838A1 (en) Compounds and their methods of use
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
MY178960A (en) Hiv treatment formulation of atazanavir and cobicistat
PH12017501979A1 (en) Pharmaceutical compound
MA40642A (fr) Nouveaux dérivés peptidiques et leurs utilisations
MX360885B (es) Nuevas composiciones antifungicas.
MX2016016381A (es) Derivados de tetrahidrotriazolopirimidina, composiciones farmaceuticas que contienen los mismos y usos.